Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Tokyo  >  Shimadzu Corporation    7701   JP3357200009

SHIMADZU CORPORATION

(7701)
  Report  
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsAnalyst Recommendations

Shimadzu Corporation : New Aggregates Sizer Aggregation Analysis System for Biopharmaceuticals Enables Real-time Quantitative Evaluation of 100 nm to 10 Ám SVP (sub-visible particle) Aggregates

share with twitter share with LinkedIn share with facebook
share via e-mail
0
07/11/2013 | 03:19am EST
Press Release
07/11/13
New Aggregates Sizer Aggregation Analysis System for Biopharmaceuticals Enables Real-time Quantitative Evaluation of 100 nm to 10 µm SVP (sub-visible particle) Aggregates

Shimadzu Corporation released the Aggregates Sizer Aggregation Analysis System for Biopharmaceuticals on July 10.

The Aggregates Sizer Aggregation Analysis System for Biopharmaceuticals offers quantitative, high-speed evaluation of 100 nm to 10 µm SVP (sub-visible particle) aggregates that may be present in biopharmaceuticals. Capable of evaluating the concentration (µg/mL) of aggregates that can cause shock symptom or other side effects, it is ideally suited for quality control and for improving the efficiency of biopharmaceutical development.

Background to Development

Biopharmaceuticals are essential to modern medicine, accounting for four of the top five products in 2012 drug sales, and the market is expected to reach $ 210 billion by 2015*. However, the generation of SVP aggregates in the sub-visible range due to mechanical stimulation or temperature changes, and the severe side effects that this induces, such as anaphylaxis (allergic systemic reactions), are concerning. Until now, no effective SVP aggregate analysis technique has been established. Shimadzu's new system significantly reduces costs and development times by allowing samples to be evaluated for aggregation at the early stages of biopharmaceutical development. In addition, it allows aggregation-prone proteins to be screened and eliminated in advance.

* Source: Cedium strategic data site

Features of the New Product 1. Quantitatively evaluates SVP range aggregate concentrations

The Aggregates Sizer measures aggregates of a wide range of particles sizes, from 7 nm to 800 µm, as part of a particle size distribution (displayed with particle quantities totaling 100 %). Furthermore, it enables quantitative evaluation (in terms of µg/mL) of aggregate concentrations in the SVP (sub-visible particle) range, from 100 nm to 10 µm.

2. Measures aggregates with sensitivity 10 times higher than previous particle size analyzers

The Aggregates Sizer is over ten times more sensitive than Shimadzu's previous SALD series particle size analyzers. This means that even micro sample quantities can be measured accurately using disposable cells for 0.4 mL sample quantities.

3. Quantitatively evaluates aggregation processes at intervals as short as one second

Changes (sizes and quantities) in aggregates can be confirmed quantitatively as a concentration (unit: µg/mL) at intervals as short as one second. This allows observing the status at various intermediate stages in order to evaluate rates of change. In addition, a batch cell (5 mL sample capacity) enables observation of aggregation processes as samples are mechanically stimulated.

distributed by
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on SHIMADZU CORPORATION
11/05SHIMADZU CORPORATION : half-yearly earnings release
10/10CORRECTION ( : Nobel Prize-Yoshino UPDATE1:)
AQ
09/27SHIMADZU CORPORATION : Ex-dividend day for interim dividend
FA
08/29Surgical Imaging Market by Modality, Technology, Application and Key Players ..
AQ
03/27SHIMADZU CORPORATION : Ex-dividend day for final dividend
FA
2018SHIMADZU CORPORATION : Ex-dividend day for interim dividend
FA
2018SHIMADZU CORPORATION : Ex-dividend day for final dividend
FA
2018SHIMADZU : Celebrates the 15th Anniversary of the Koichi Tanaka Mass Spectrometr..
PU
2018SHIMADZU : Less than a teaspoon of blood can predict Alzheimer's disease risk.
PU
2018SHIMADZU : New Nexera Mikros, a Micro Flowrate Compatible Liquid Chromatograph M..
PU
More news
Financials (JPY)
Sales 2020 400 B
EBIT 2020 45 692 M
Net income 2020 33 162 M
Finance 2020 69 736 M
Yield 2020 0,91%
P/E ratio 2020 29,6x
P/E ratio 2021 26,7x
EV / Sales2020 2,28x
EV / Sales2021 2,14x
Capitalization 981 B
Technical analysis trends SHIMADZU CORPORATION
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 11
Average target price 3 608,00  JPY
Last Close Price 3 330,00  JPY
Spread / Highest target 26,1%
Spread / Average Target 8,35%
Spread / Lowest Target -11,4%
EPS Revisions
Managers
NameTitle
Teruhisa Ueda President, CEO & Representative Director
Akira Nakamoto Chairman
Shin Bandai Manager-Finance & Accounting
Yasunori Yamamoto Head-Information Systems & Manufacturing
Hiroshi Fujino Director & Senior Managing Executive Officer
Sector and Competitors
1st jan.Capitalization (M$)
SHIMADZU CORPORATION59.10%9 024
SMC CORPORATION55.04%30 596
METTLER-TOLEDO INTERNATIONAL, INC.34.55%18 534
COGNEX CORPORATION32.89%8 782
MKS INSTRUMENTS, INC.67.50%5 899
RENISHAW PLC-8.02%3 722